Back to Journals » ImmunoTargets and Therapy » Volume 2

ImmunoTargets and Therapy


Archive: Volume 2, 2013

Therapeutic vaccines in non-small cell lung cancer

Socola F, Scherfenberg N, Raez LE

ImmunoTargets and Therapy 2013, 2:115-124

Published Date: 19 September 2013

Anti-amyloid-beta to tau-based immunization: developments in immunotherapy for Alzheimer's disease

Lambracht-Washington D, Rosenberg RN

ImmunoTargets and Therapy 2013, 2:105-114

Published Date: 12 August 2013

Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities

Graves A, Hessamodini H, Wong G,Lim WH

ImmunoTargets and Therapy 2013, 2:73-90

Published Date: 23 July 2013

Allergen immunotherapy: routes, safety,efficacy, and mode of action

Hochfelder JL, Ponda P

ImmunoTargets and Therapy 2013, 2:61-71

Published Date: 23 July 2013

Immunotargeting in the management of psoriasis

Kaffenberger BH, Kaffenberger TM, Wong HK

ImmunoTargets and Therapy 2013, 2:51-60

Published Date: 1 July 2013

Update on the challenges and recent advances in cancer immunotherapy

Baronzio G, Parmar G, Shubina IZH, Cassutti V, Giuli S, Ballerini M, Kiselevsky M

ImmunoTargets and Therapy 2013, 2:39-49

Published Date: 17 June 2013

The association between Lambert–Eaton myasthenic syndrome and small cell lung carcinoma

Briggs SEW, Gozzard P, Talbot DC

ImmunoTargets and Therapy 2013, 2:31-37

Published Date: 22 May 2013

Update on immunopathogenesis and immunotherapy in multiple sclerosis

Selter RC, Hemmer B

ImmunoTargets and Therapy 2013, 2:21-30

Published Date: 26 April 2013

Cancer testis antigen and immunotherapy

Krishnadas DK, Bai F, Lucas KG

ImmunoTargets and Therapy 2013, 2:11-19

Published Date: 18 April 2013

Immunotherapy in the management of melanoma: current status

Alston D, Brewer JD

ImmunoTargets and Therapy 2013, 2:1-10

Published Date: 26 February 2013